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Theprotein enhancer of rudimentary homolog, ERH, is a small, highly conserved protein that has been found in animals, plants, and
protists. Genetic and biochemical interactions have implicated ERH in the regulation of pyrimidine biosynthesis, DNA replication,
transcription, mRNA splicing, cellular proliferation, tumorigenesis, and the Notch signaling pathway. In vertebrates and insects,
ERH is nuclearly localized; however, an examination of the ERH amino-acid sequence does not reveal any nuclear localization
signals. In this paper we show that the first 24 amino acids contain sequences necessary and sufficient for nuclear localization.
Through yeast two-hybrid screens, three new binding partners of ERH, RPS3, RPL19, andDDIT4, were identified. RPS3was isolated
from both human and Drosophila screens. These interactions suggest functions of ERH in cell growth, cancer, and DNA repair.
The ERH sequences necessary for the interactions between ERH and RPS3 and RPL19 are mapped onto the same 24-amino-acid
region in ERH which are necessary for nuclear localization, suggesting that ERH is localizing to the nucleus through binding to
one of its DNA-binding partners, such as RPS3 or RPL19.
1. Introduction
The Drosophila enhancer of rudimentary, e(r), gene encodes
enhancer of rudimentary homolog (ERH), a small protein of
104 amino acids [1, 2]. ERH is a highly conserved protein
that has been found in plants, animals, and protists [2].
Drosophila ERH is 76% identical to the vertebrate ERH, 49%
identical to theC. elegans ERH, and 40% identical to the plant
(Arabidopsis) ERH.The vertebrate ERHhomologues are very
highly conserved. The human, mouse, and Xenopus proteins
are identical and differ from the zebrafish ERH by a single
conservative amino-acid change.
The mouse and human proteins have been synthesized
and purified from E. coli and the crystal structures deter-
mined [3, 4]. The secondary structure is very similar to
the predicted secondary structure [2]. The protein contains
three 𝛼-helices and a 𝛽-sheet that fold into a novel three-
dimensional structure that comprises a single domain. The
𝛽-sheet is formed by four antiparallel 𝛽-strands. In vitro,
human ERH exists as a dimer and the dimerization occurs
via binding between the 𝛽-sheets of the two monomers.
The binding is accomplished through primarily seven highly
conserved amino acids (Figure 1).
A number of studies in vertebrates have indicated that
ERH has a nuclear function. Yeast two-hybrid screens have
identified possible nuclear partners for ERH.These include a
transcription factor, DCoH/PCD in Xenopus [5], a protein
involved in the regulation of DNA replication in humans,
PDIP46/SKAR [6], and Ciz1, a nuclear zinc-finger protein
that may regulate DNA synthesis and cyclin dependent
kinases in humans [7, 8]. ERH has been shown to coim-
munoprecipitate with SPT5, a transcription elongation factor
[9], and with FCP1, a TFIIF-associating component of CTD
phosphatase [10]. ERH has also been shown to interact with
the spliceosome protein SNRPD3 and to be required for the
splicing of the mRNA of CENP-E, a mitotic motor protein
[11].This diverse set of nuclear interactions suggests that ERH
may be involved in a number of general nuclear functions
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D.m. MSHTILLVQPGARPETRTYCDYESVNECMEGVCKIYEEHLKRRNPNTPTIT
H.s. MSHTILLVQPTKRPEGRTYADYESVNECMEGVCKMYEEHLKRMNPNSPSIT
60 70 80 90 100
D.m. YDISQLFDFIDTMVDISCMVYQKSTNTYAPYNKDWIKEKIYVLLRQAAFSSNT
H.s. YDISQLFDFIDDLADLSCLVYRADTQTYQPYNKDWIKEKIYVLLRRQAQQAGK
Figure 1: Comparison of the primary structures of the Drosophila and human ERH. The two proteins align perfectly without any gaps over
their entire length.They are 76% identical. The positions of the seven amino acids that have been determined to be points of contact between
the subunits of the ERH dimer are underlined. Six out of the seven are conserved between Drosophila and human, and the seventh (L to M)
is a very conservative change. The N-terminal 24 amino acids that are necessary and sufficient for the nuclear localization of the Drosophila
ERH and for the interactions with RPS3 and RPL19 are in italic.
involving DNA replication, transcription, and mRNA splic-
ing.These studies also predict that ERH is nuclearly localized.
This prediction is supported by the nuclear localization of an
EGFP-ERH fusion protein in transfected NIH/3T3 cells [6].
Further studies with antibodies to Drosophila ERH showed
that the endogenous ERH is localized to the nucleus in
Drosophila Schneider cell lines and in cells of the early
Drosophila embryo [12].
Searches for potential nuclear localization signals in
Drosophila and humanERHby computer programs designed
to identify nuclear localization signals (PredictProtein,WoLF
PSORT, and cNLS mapper) fail to identify any. This presents
the question as to how ERH is nuclearly localized. In this
paper we define the sequence needed for the nuclear localiza-
tion of ERH and describe the identification of new potential
nuclear binding partners of ERH. The amino-acid sequences
of ERH that are necessary for binding to its partners and for
its nuclear localization are the same.This suggests that ERH is
nuclearly localized through binding to these proteins or other
binding partners.
2. Materials and Methods
2.1. The Yeast Two-Hybrid Interaction Trap and Interaction
Assay. For these procedures, all of the yeast strains, plasmids,
and cDNA prey libraries were obtained from the labs of
Dr. Roger Brent while he was at Harvard University and
Dr. Russ Finley (http://proteome.wayne.edu/index.html).
Detailed procedures can be obtained from Dr. Finley’s web-
site. The host Saccharomyces cerevisiae strain EGY191 is a
his3, ura3, trp1, and leu2 auxotroph carrying a chromosomal
insertion of LexA binding sites upstream of the endogenous
LEU2 gene. This strain also contained the plasmid pRB1840,
which contains LexA DNA-binding sites in front of a LACZ
reporter gene. EGY191/pRB1840 was then transformed with
the bait plasmid pEG202 containing the appropriate LexA-
e(r) fusion gene to be used in the interaction-trap screens or
the interaction assays.
2.2. Full-Length Human and Drosophila ERH as the Bait. The
D. melanogaster e(r) coding region was amplified from an
e(r) cDNA via PCR using the primers 5󸀠 GGGGATCCC-
CATGTCGCACACCATCCT 3󸀠 and 5󸀠 GGCTCGAGTTAG-
GTATTG GAACTAA 3󸀠 (Table 1), digested with BamHI
and XhoI, and ligated into the polylinker of the parent bait
plasmid pEG202 as a BamH1-Xho1 fragment. The human
e(r) coding region was amplified via PCR using the
primers 5󸀠 TGGAATTCATGTCTCACACCATTTTG 3󸀠 and
5󸀠 CTCGAGTTATTTCCCAGCCTGTT 3󸀠 (Table 1), digested
with EcoRI and XhoI, and ligated into the polylinker of
pEG202 as an EcoR1-Xho1 fragment. These procedures
fuse the e(r) genes in frame with the LexA DNA-binding
domain. EGY191/pRB1840 was transformed with either the
Drosophila e(r) as the bait, pEG202-DER, or the human
e(r) as the bait, pEG202-HER. Bait proteins expressed from
pEG202 will enter the yeast nucleus and bind LexA operators
upstream of the two reporter genes LEU2 and LACZ but,
alone, will fail to activate their transcription.
2.3. Screening the Drosophila and Human cDNA Libraries. A
Drosophila 0–12-hour embryo cDNA library was screened
for genes encoding ERH-interacting proteins.The library was
created in the plasmid pJG4-5 and contains 4 × 106 indepen-
dent clones [13]. The prey genes in the library consist of a
transcription activation domain fused to a random cDNA. If
the coding region encodes an ERH-binding protein, then it
will bind to LexA-ERH at the LexA promoters of the LEU2
and LACZ genes. This will result in the activation of both
genes resulting in a LEU2+ LACZ+ colony. Another require-
ment of the screen is that the LEU2+ LACZ+ phenotypes
be galactose-dependent, since the prey genes are under the
control of a Gal1 promoter. The EGY191/pRB1840/pEG202-
DER strain was first transformed with the pJG4-5 cDNA
library, and a total of 102,000 transformants were isolated.
These colonies served as the stock for further screening. Next
LEU2+ colonies were isolated from the stock on minimal
medium containing galactose. A total of 5213 colonies were
isolated as putative galactose-dependent LEU2+ colonies.
Upon retesting, 172were galactose-dependent.These colonies
were then tested for galactose-dependent LACZ+ phenotype.
Of the 172 colonies, 12 were galactose-dependent LACZ+.
Finally, the library plasmid from each of these colonies was
isolated and retested for its dependence on the bait plasmid,
pEG202-DER, for producing the galactose-dependent LEU2+
LACZ+ phenotype. Eight of these clones proved to be bait-
dependent and were saved for further analysis.
A HeLa cell cDNA library was screened to isolate genes
encoding human proteins that interact with human ERH. A
similar procedure to the Drosophila screen was performed
except that pEG202-HER was used. A total of 73,000 individ-
ual colonies transformed with the HeLa cDNA library. These
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Table 1: Primers used in the construction of e(r) fusion genes.
Species Target Primer sequences 5󸀠 to 3󸀠 Vector Restriction site
H.s. ERH 1 5󸀠 TGGAATTCATGTCTCACACCATTTTG pEG202 EcoRI
H.s. ERH 52 5󸀠 TGGAATTCTATGACATCAGTCAGTTGTTT pEG202 EcoRI
H.s. ERH 51 3󸀠 TGCTCGAGTTATGTGATAGAGGGACT pEG202 XhoI
H.s. ERH 104 3' GGCTCGAGTTATTTCCCAGCCTGTT pEG202 XhoI
D.m. ERH 1 5󸀠 GGGGATCCCCATGTCGCACACCATCCT pEG202 BamHI
D.m. ERH 25 5󸀠 GGGGATCCCCGTCAACGAGTGCATGGG pEG202 BamHI
D.m. ERH 52 5󸀠 GGGGATCCCCTATGACATTAGCCAGCTATTC pEG202 BamHI
D.m. ERH 24 3󸀠 CCCTCGAGTTAGCTCTCGTAGTCACAGTA pEG202 XhoI
D.m. ERH 51 3󸀠 CCCTCGAGTTACGTAATGGTCGGAGTGTT pEG202 XhoI
D.m. ERH 104 3󸀠 GGCTCGAGTTAGGTATTGGAACTAA pEG202 XhoI
H.s. ERH 1 5󸀠 AGATCTCGAGCTATGTCTCACACCATTTTGCTGG pEGFP-C1 XhoI
H.s. ERH 52 5󸀠 TGCTCGAGCTTATGACATCAGTCAGTTGTTT pEGFP-C1 XhoI
H.s. ERH 51 3󸀠 TGGGATCCTTATGTGATAGAGGGACT pEGFP-C1 BamHI
H.s. ERH 104 3󸀠 GGTTTCGGATCCCGATTGAACAAGATCCTCAC pEGFP-C1 BamHI
e(r) sequence starts within the 3󸀠 UTR.
D.m. ERH 1 5󸀠 GGCTCGAGCTATGTCGCACACCATCCT pEGFP-C1 XhoI
D.m. ERH 25 5󸀠 GGCTCGAGCTGTCAACGAGTGCATGGAGGG pEGFP-C1 XhoI
D.m. ERH 52 5󸀠 GGCTCGAGCTTATGACATTAGCCAGCTATTC pEGFP-C1 XhoI
D.m. ERH 24 3󸀠 CCGGATCCTTAGCTCTCGTAGTCACAGTA pEGFP-C1 BamHI
D.m. ERH 51 3󸀠 CCGGATCCTTACGTAATGGTCGGAGTGTT pEGFP-C1 BamHI
D.m. ERH 104 3󸀠 CCGGATCCTTAGGTATTGGAACTAA pEGFP-C1 BamHI
The target indicates the amino-acid codon that starts the e(r) sequence in the primer and the position of the primer. In the primer sequence, the restriction site
is underlined and the starting codon is double underlined and in bold. For the 3󸀠 primers, the stop codon is italicized. For the H.s. ERH 104 3󸀠 for pEGFP-C1
the primer starts in the 3󸀠 UTR, so there is not a stop codon in this primer. D.m., Drosophila melanogaster; H.s., Homo sapiens.
produced 18 galactose-dependent LEU2+ LACZ+ colonies.
From these five bait-dependent colonies were identified for
further analysis.
2.4. Identifying the ERH-Interacting Proteins. Plasmid DNA
from the positive clones was isolated and used as the
template for PCR. Two pJG4-5 specific primers 5󸀠 CCA-
GCCTCTTGCTGAGTGGAGATG 3󸀠 and 5󸀠 GACAAG-
CCGACAACCTTGATTGGA 3󸀠 were used. These primers
flank the EcoRI and XhoI sites in pjG4-5 and can be used
to amplify the inserted cDNA. The amplified DNA was
sequenced and homology searches using BLAST (https://
blast.ncbi.nlm.nih.gov/Blast.cgi) were performed to identify
the clones.
2.5. Coimmunoprecipitation of LexA-DER and HA-RPS3.
Yeast expressing LexA-DER and HA-RPS3 was grown in
50mL minimal galactose medium at 30∘ with shaking for 48
to 72 hours. To verify the expression of LexA-ERH, one mL
of the growth culture was removed to amicrocentrifuge tube.
The cells were pelleted by centrifugation in a microcentrifuge
for 5min at 12,000 rpm, the supernatant was removed, and
the pellet was resuspended in 40 𝜇L Laemmli loading buffer
(Bio-Rad Laboratories, Inc.) with 𝛽-ME. After resuspension,
the sample was stored at −20∘ until being analyzed by SDS-
PAGE. The remaining culture was centrifuged at 3000 rpm
for 15min to pellet the cells. The pellet was resuspended in
5mL CIP buffer (50mM Tris-HCl pH 7.5, 100mMNaCl, and
5mM EDTA 0.1% triton X-100) and protease inhibitor and
cooled on ice. A volume of glass beads (Sigma-Aldrich) equal
to the volume of the cell pellet was added, and the sample was
vortexed 5 times at 30 seconds bursts to shear the cells, with
cooling on ice between vortexes. Cell debris was removed
from the sample by centrifugation at 3,000 rpm for 5 minutes
at 4∘. The protein containing supernatant was removed and
kept on ice.
A rabbit polyclonal anti-HA antibody (Santa Cruz Bio-
technology) was added (1 : 500) to the sample and incubated
on ice for 1 hour, with brief mixing in between. 100𝜇L
of protein A beads (Pierce Chemical Co.) was added and
allowed to incubate for 1 hour on ice. Brief mixing of the
sample was done throughout the 1-hour incubation to keep
the beads in suspension. The sample was centrifuged for 3
minutes at 1,500 rpm to pellet the beads and the supernatant
was removed. The beads were washed 4 times in 10mL of
CIP buffer. The final bead pellet was resuspended in 40 𝜇L
Laemmli loading buffer with 𝛽-ME and boiled for 1 minute.
As a negative control, yeast expressing LexA and HA-
RPS3was treated in parallel with the sample above.Also, yeast
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expressing HA and LexA-DER was treated in the same man-
ner to insure DER was not sticking to the protein A beads.
40 𝜇L of each sample was loaded in the order: crude yeast
extract expressing LexA/HA-RPS3, yeast extract expressing
LexA/HA-RPS3 treated with anti-HA, crude yeast extract
expressing LexA-DER/HA-RPS3, yeast extract expressing
LexA-DER/HA-RPS3 treated with anti-HA, crude yeast
extract expressing LexA-DER/HA, yeast extract expressing
LexA-DER/HA treated with anti-HA, and marker.
The samples were run on a 10% polyacrylamide gel
(Invitrogen NuPage, NP0341BOX) in 1x Invitrogen NuPage
MES SDS Running Buffer (NP0002) and transferred to a
nitrocellulose membrane (Pierce Chemical Co.) using Invit-
rogen NuPage transfer buffer (NP0006) via electroblotting
using a Bio-Rad Trans-Blot SD Semi-Dry Transfer Cell and
an EC150 (E-C Apparatus Corporation) power source at 20V
for one hour.
After transfer, total proteinwas detected using a reversible
membrane protein staining solution (Pierce Chemical Co.).
The membrane was blocked in blocking buffer (5% fat-
free powdered milk in TTBS: 9.68 g Tris buffer, 116.96 g
NaCl, 1760 𝜇L Tween-20 in 4 L dH2O, pH to 7.5) for one
hour before probing following standard Western techniques.
The membrane was probed with a goat anti-LexA antibody
(1 : 1000) in blocking buffer for one hour with gentle shaking.
The membrane was rinsed 3 times in TTBS over a one-hour
period. The goat anti-LexA antibody was detected with a
mouse anti-goat IgG-HRP conjugated secondary antibody
(1 : 5000) for one hour with gentle shaking. The membrane
was rinsed and the conjugatewas detected using SuperSignal
West Femto Substrate (Pierce Chemical Co.) and the blot
exposed on film.
2.6. Mapping the Interacting Region(s) of ERH. To map
the regions of the human and Drosophila ERH that were
necessary for interacting with their partners, sets of primers
were used to amplify different regions of the coding sequence
for ligating to the LexA coding region in pEG202 (Table 1).
For the Drosophila ERH these primers were used to amplify
coding sequences for amino acids 1–51, 52–104, 1–24, and
25–51. Each amplified sequence was digested with BamHI
and XhoI and ligated into pEG202. For the human ERH,
coding sequences for amino acids 1–51 and 52–104 were
amplified, digested with EcoRI and XhoI, and ligated into
pEG202. The newly constructed baits were transformed into
EGY191/pRB1840/pJG4-5-RpS3 or EGY191/pRB1840/pJG4-
5-RPL19 and tested for the galactose-dependent LEU2+
LACZ+ phenotype.
2.7. Mapping the Nuclear Localization Signal of ERH. GFP-
ERH constructs were generated by cloning the human and
Drosophila e(r) fragments encoding amino acids 1–104, 1–
51, and 52–104 and the Drosophila ERH fragments 1–24 and
25–51 into the expression vector pEGFP-C1. Specific primer
pairs (Table 1) were used to amplify the sequences, which
were digested with BamHI and XhoI and ligated into pEGFP-
CI. This procedure fuses the fragments in frame to the C-
terminus of GFP. Each plasmid was used to transform SK-
HEP cells [14]. SK-HEP cells were grown in EMEM plus
10% calf serum for two days to allow them to adhere to
round microscope slide covers. SK-HEP cells were supplied
by Dr. Barry Bode, Department of Biology, Saint Louis Uni-
versity (current address Department of Biological Sciences,
Northern Illinois University). Prior to transfecting the cells,
the transfection mix was prepared as follows: 1𝜇g DNA was
added to 389 𝜇L Eagle’s minimal essential medium, EMEM
(serum-free), and vortexed. To this mix, 9 𝜇L of TfX-20
Reagent (Promega Corporation) was added, and the mix was
vortexed and allowed to incubate for 10–15min at room temp.
After the incubation period, the growth medium was aspi-
rated off the cells, and the transfectionmixwas added directly
to the cells. The cells were returned to the 37∘ incubator for
2 hours. At the end of the incubation period, 300 𝜇L EMEM
with 10% calf serumwas added to the cells, without removing
the transfectionmix.The cells were returned to the incubator
and allowed to grow for another two days before viewingwith
a fluorescent compound microscope with a GFP filter.
3. Results
3.1. Identification of Potential Binding Partners of ERH. To
identify possible binding partners for Drosophila ERH, a
yeast two-hybrid screen [15] was performed usingDrosophila
LexA-ERH as bait to screen a prey library consisting of
Drosophila embryo cDNA clones fused to the transcription
activation domain of Gal4. To construct the LexA-ERH
fusion gene, PCR was performed to amplify the e(r) coding
regionwith restriction sites for cloning into pEG202 (Table 1).
Positive prey colonies were seen as galactose-dependent
LEU2+ LACZ+ colonies. Eight positive colonies out of 102,000
transformants were isolated. The prey plasmid from each
positive clone was isolated and a partial sequence of the
cDNA insert was determined to identify the putative ERH-
binding partner. Five of the clones were of RPS3 (ribosomal
protein S3) and three of the clones were of RPL19 (ribosomal
protein L19).
Another yeast two-hybrid screen was performed using
the human ERH as bait and a human HeLa cell cDNA prey
library. Five positive colonies were identified out of 73,000
transformants.Three of the clones were humanRPS3 and two
were human DDIT4 (DNA damage inducible transcript 4).
All of the putative binding partners of DmERH and
HsERH are known nuclear proteins, which is consistent with
previous studies that localized ERH to the nucleus [6, 12].The
fact that RPS3 was identified as a binding partner of ERH in
both Drosophila and humans suggests a conserved function
of ERH in both humans and Drosophila.
3.2. Verification of the Binding of ERH and RPS3 via Coim-
munoprecipitation. The yeast two-hybrid screen is a genetic
test to show protein-protein interactions. To verify that
Drosophila ERH and RPS3 actually bind to each other,
experiments to show coimmunoprecipitation of ERH and
RPS3 were performed. The first experiment was designed
to show the requirement for the presence of RPS3 for the
precipitation of ERH. Yeast cells were grownwhich expressed
LexA-ERH and either HA orHA-RPS3. Protein extracts from
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Figure 2: Western blots probed with anti-LexA, showing that ERH and RPS3 bind to each other and can be coimmunoprecipitated. (a)
Requirement of RPS3 for coimmunoprecipitation. This blot shows that RPS3 must be attached to HA in order for the HA antibody to
coprecipitate LexA-ERH. (1)Molecular weightmarkers.Thesewere superimposed from a photograph of the stained gel. (2) Extracts from cells
expressingHA-RPS3 and LexA-ERH. (3) Immunoprecipitates of extracts from cells expressingHA-RPS3 and LexA-ERH immunoprecipitated
with anti-HA antibody. (4) Extracts from cells expressing HA and LexA-ERH. (5) Immunoprecipitates of extracts from cells expressing HA
and LexA-ERH that have been immunoprecipitated with anti-HA antibody. (b) Requirement of ERH for coimmunoprecipitation. This blot
shows that ERH must be attached to LexA in order for the HA antibody to coprecipitate LexA and rules out the possibility that RPR3 binds
to LexA alone. (1) Extracts from cells expressing HA-RPS3 and LexA. (2) Immunoprecipitates of extracts from cells expressing HA-RPS3 and
LexA and immunoprecipitated with anti-HA antibody. (3) Molecular weight markers. These were superimposed from a photograph of the
stained gel. Together the two blots show that both RPS3 and ERH are necessary to get coimmunoprecipitation and confirm that RPS3 and
ERH are binding partners.
each cell type were isolated and immunoprecipitated with
anti-HA. LexA-ERH was not present in the immunopre-
cipitate from the cells expressing HA (Figure 2(a), lane 5)
but was present in the immunoprecipitate from the cells
expressing HA-RPS3 (Figure 2(a), lane 3). Controls showed
that both cell types expressed LexA-ERH (Figure 2(a), lanes
2 and 4). While these experiments showed that RPS3 is
necessary for the immunoprecipitation of LexA-ERH, RPS3
could conceivably bind to either LexA or ERH. To show that
RPS3 was not binding to LexA, a protein extract was isolated
from cells expressing HA-RPS3 and LexA. The extracts
were precipitated with anti-HA. In this case LexA did not
coprecipitate, demonstrating the necessity for ERH in the
coimmunoprecipitation (Figure 2(b), lane 2).
3.3. Mapping Interacting Portion of DmERH and HsERH with
RPS3 and RPL19. Structural studies on purified human ERH
reveal that the protein likely forms a single domain with three
𝛼-helices and one 𝛽-sheet composed of four antiparallel 𝛽-
strands [3, 4]. The crystal structure also suggests that the 𝛽-
sheet serves as a surface for protein-protein binding. Given
this structural information, it was of interest to determine
the amino-acid sequences of ERH that are necessary for its
binding to its partners, RPS3 and RPL19. The yeast two-
hybrid interaction assay was used to map the ERH sequences
necessary for binding. PCR was used to amplify specific
regions of the ERH coding region, which were then ligated
into the LexA bait plasmid, pEG202 (Table 1). In this way,
LexA-ERH baits containing Drosophila ERH amino acids 1–
51, 52–104, 1–24, and 25–51 were generated and tested for
their ability to interact with RPS3 and RPL19. The results are
Table 2: Drosophila ERH interactions with its partners.
ERH bait segment Prey protein Interaction
1–104 D.m. RPS3 +
1–104 H.s. RPS3 +
1–104 D.m. RPL19 +
1–51 D.m. RPS3 +
1–24 D.m. RPS3 +
1–24 D.m. RPL19 +
52–104 D.m. RPS3 −
25–51 D.m. RPS3 −
The table summarizes the bait-prey interactions performed in the yeast two-
hybrid interaction assay. The amino acid segments of the ERH baits are
given. A + interaction indicates that yeast containing a prey and the bait
exhibits both the galactose-dependent growth on medium lacking leucine
(LEU+) and the galactose-dependent beta-galactosidase activity (LACZ+)
on medium containing X-gal. A − interaction indicates that the yeast failed
both of the galactose-dependent assays. D.m.,Drosophila melanogaster; H.s.,
Homo sapiens.
summarized in Table 2. As a positive control, the full-length
ERH (1–104) was shown to bind to RPS3. It also binds to the
human RPS3, indicating that this protein-protein interaction
is conserved. Amino acids 1–51 were shown to bind to RPS3
and RPL19, whereas amino acids 52–104 did not. Amino acids
1–51 were then subdivided into 1–24 and 25–51. Amino acids
1–24 bind to RPS3 and RPL19, while amino acids 25–51 do
not. This maps the sequences necessary for binding to amino
acids 1–24.
A similar mapping experiment was performed with
HsERH and HsRPS3. In these experiments the human ERH
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Table 3: Human ERH interactions with its partners.
ERH bait segment Prey protein Interaction
1–104 H.s. RPS3 +
1–104 H.s. DDIT4 +
1–51 H.s. RPS3 +
52–104 H.s. RPS3 −
The table summarizes the bait-prey interactions performed in the yeast two-
hybrid interaction assay. The amino acid segments of the ERH baits are
given. A + interaction indicates that yeast containing a prey and the bait
exhibits both the galactose-dependent growth on medium lacking leucine
(LEU+) and the galactose-dependent beta-galactosidase activity (LACZ+) on
medium containing X-gal. A− interaction indicates that the yeast failed both
of the galactose-dependent assays. H.s., Homo sapiens.
was subdivided into amino acids 1–51 and 52–104 and exam-
ined for their ability to bind to HsRPS3. Similar to the results
withDmERH, amino acids 1–51 bind toHsRPS3, while amino
acids 52–104 do not (Table 3).
3.4. Mapping ERH Sequences Necessary for Nuclear Local-
ization. Previous studies on the immunolocalization of ERH
in Drosophila S2 cells and early embryos demonstrated that
in Drosophila melanogaster endogenous ERH is nuclearly
localized [12]. Those results corroborate studies in human
cell lines in which EGFP-HsERH fusion proteins were local-
ized to the nucleus [6]. These data argue that ERH must
have a nuclear localization signal; however, scans of the
Drosophila and human ERH amino-acid sequences using
PredictProtein (http://PredictProtein.org/), WoLF PSORT
(http://www.genscript.com/wolf-psort.html/), and cNLS
mapper (http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS Map-
per form.cgi/) have not revealed any nuclear localization
signals. This leaves unanswered the questions as to how ERH
is nuclearly localized andwhat amino-acid sequences are nec-
essary for nuclear localization. We decided to utilize the GFP
system to identify the sequences necessary for the nuclear
localization of ERH. Both Drosophila ERH and human ERH
were utilized in the study. Human SK-HEP cells were used as
the host cells in the assay. PCR was used to amplify all or part
of the coding regions for ligation into the plasmid, pEGFP-
C1, for the creation ofGFP-DmERHandGFP-HsERH fusions
(Table 1). These fusions result in appending ERH fragments
onto the C-terminus of EGFP. Plasmids containing the
fusion genes were transfected into human SK-HEP cells and
cellular localization was visualized with GFP. The results are
summarized in Table 4. For both ERH and HERH, the full-
length protein localizes to the nucleus (Figures 3(a) and 4(a)).
The N-terminal half of each protein (amino acids 1–51) can
also direct nuclear localization (Figures 3(b) and 4(b)), while
the C-terminal half of each protein (amino acids 52–104)
does not (Figures 3(c) and 4(c)). For Drosophila ERH, the
N-terminal half was further subdivided into amino acids 1–
24 and 25–51. Amino acids 1–24 direct the localization of
GFP to the nucleus (Figure 3(d)), although there appeared to
be more cytoplasmic expression of GFP than what was seen
when amino acids 1–51 (Figure 3(b)) or the entire protein
(Figure 3(a)) was used. Amino acids 25–51 fail to nuclearly
localize GFP (Figure 3(e)). These data localize the minimal
Table 4: EGFP-ERH nuclear localization in human SK-HEP cells.
Species ERH segment Nuclear
D.m.
1–104 +
1–51 +
1–24 +
52–104 −
25–51 −
H.s.
1–104 +
1–51 +
52–104 −
The cellular localization of the EGFP-ERH fusion proteins is given. A
strong nuclear localization is given a positive score. Both a nuclear and
cytoplasmic localization similar to that of EGFP alone is given a negative
score. The evaluations were made from the microscopic examinations of
EGFP localization, examples of which are shown in Figures 3 and 4. D.m.,
Drosophila melanogaster; H.s., Homo sapiens.
sequence needed for nuclear localization to amino acids 1–
24. As a negative control, EGFP by itself does not nuclearly
localize (Figure 4(d)).
4. Discussion
The data argue that the first 24 amino acids are sufficient
for the nuclear localization of ERH. There are two arginines
within this region of Drosophila ERH, but nothing looks like
a nuclear localization signal. Interestingly, this 24-amino-acid
region is the same region that is necessary for ERH to bind to
its binding partners, RPS3 and RPL19 (Table 2). Both of these
proteins contain nuclear localization signals, as identified
by cNLS mapper. The Drosophila RPS3 in particular has
a strong NLS starting at amino acid 6 (PISKKRKFV). The
human RPS3 has a similar NLS starting at amino acid 4
(QISKKRKFV). In addition, RPS3 has been shown to localize
to the nucleus in both Drosophila melanogaster [16] and
humans [17]. Together these data suggest that ERH may be
entering the nucleus through piggy backing onto one of its
binding partners, such as RPS3.
TheN-terminal 24-amino-acid region, which is necessary
for both the nuclear localization of ERH and its binding to
RPS3 and RPL19, is comprised of two antiparallel 𝛽-strands
that are part of a four-strand 𝛽-sheet. This 𝛽-sheet serves
as a hydrophobic surface in protein binding [3, 4]. Five
out of the seven residues within the 𝛽-sheet, which have
been identified as important in the dimerization of ERH, are
contained within the first two 𝛽-strands. These amino acids
are 5I, 7L, 17R, 19Y, and 21D. These residues are conserved
between human and Drosophila ERH (Figure 1), suggesting
their importance in protein binding in both species, and may
explain how Drosophila ERH can bind to both Drosophila
and human RPS3. Our current results also indicate that while
the four strands of the𝛽-sheet form a face for protein binding,
the first two 𝛽-strands are necessary and sufficient for protein
binding and nuclear localization. Although amino acids 1–24
are sufficient for nuclear localization, this sequence appears
not to localize GFP to the nucleus as strongly as do amino
acids 1–52 and 1–104 (Figure 3). These additional amino
Molecular Biology International 7
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(e)
Figure 3: Drosophila ERH sequences necessary for nuclear localization. The cellular localization of fusion proteins containing fragments
of Drosophila ERH fused to EGFP was examined in transfected human SK-HEP cells. These experiments show that amino acids 1–24 are
necessary and sufficient to localize EGFP to the nucleus. (a)The entire protein, amino acids 1–104, fused to EGFP. (b) Amino acids 1–51 fused
to EGFP. (c) Amino acids 52–104 fused to EGFP. (d) Amino acids 1–24 fused to EGFP. (e) Amino acids 25–51 fused to EGFP.
acids (25–104) are not sufficient for nuclear localization, but
they may help stabilize the structure of amino acids 1–24
for optimal protein binding. Amino acids 25–52 comprise a
major 𝛼-helix that is positioned behind the two 𝛽-strands of
amino acids 1–24. This structure may aid in presenting the
two 𝛽-strands to ERH’s binding partners. Amino acids 66–
82 comprise the last two 𝛽-strands that, along with amino
acids 1–24, form the 𝛽-sheet that is necessary for the binding
of ERH to its partners. These 𝛽-strands, while helping to
stabilize the 𝛽-sheet, also contain two amino acids that
have been shown to be contact points in protein-protein
binding of ERH. These amino acids should strengthen the
interactions and thus strengthen the nuclear localization of
ERH.
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(c) (d)
Figure 4: Human ERH sequences necessary for nuclear localization. The cellular localization of fusion proteins containing fragments of
human ERH fused to EGFP was examined in transfected human SK-HEP cells. These experiments show that amino acids 1–51 are necessary
and sufficient to localize EGFP to the nucleus. (a) The entire protein, amino acids 1–104, fused to EGFP. (b) Amino acids 1–51 fused to EGFP.
(c) Amino acids 52–104 fused to EGFP. (d) EGFP by itself.
The present studies identified three new putative binding
partners for ERH, RPS3, and RPL19 in Drosophila and RPS3
and DDIT4 in humans. There are some common themes
in the functions of these proteins. RPS3, besides being a
ribosomal protein, is a DNA repair enzyme [16, 18] and
DDIT4 is a protein whose expression is induced in response
to DNA damage [19]. Also, human RPS3 has been shown to
translocate from the cytoplasm to the nucleus in response
to genotoxic stress treatment with hydrogen peroxide or
DNA alkylating agents [20]. These findings suggest the
possibility that ERH has a role in DNA damage repair and
that this function can be regulated by regulating its nuclear
localization through its binding to RPS3.
There is a high evolutionary conservation between the
human and Drosophila ERH. Both are 104 amino acids in
length and can be lined up without gaps along their entire
lengths [2]. Additionally, the two proteins show 76% amino
acid identity and 84% similarity [2]. The tertiary structure
or the Drosophila ERH [21], predicted by SWISS-MODEL
[22], is nearly identical to the solved tertiary structure of the
human/mouse ERH [3, 4]. For the human/mouse ERH, seven
amino acids were identified as critical in protein binding (5I,
7L, 17R, 19Y, 21D, 70L, and 79Y). Six of these seven amino
acids are strictly conserved in the Drosophila ERH [21]. The
one difference is a conservation amino acid substitution at
residue 70 (M for L). The first five of these amino acids
are contained within the N-terminal 24 amino acids that
this study has shown to be important for both binding of
ERH to RPS3 and RPL19 and the nuclear localization of
ERH. This high structural conservation suggests that the
human and Drosophila ERHmay be functionally equivalent.
Recently, this has been demonstrated through transgenic
studies [21]. In these studies, the Drosophila ERH coding
region was replaced with the human ERH coding region
in the Drosophila genome without any noticeable effect on
the fly. All of the known mutant phenotypes associated with
the deletion of the Drosophila e(r) gene were rescued by
the human e(r) gene, indicating that the human ERH can
functionally replace the Drosophila ERH.
The evolutionary conservation in the structure and func-
tion of the human and Drosophila ERH suggest that its
roles in the cell may also be conserved between humans
and Drosophila. Given this possibility, the fact that the
present study identified RPS3 as a possible binding partner
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for both the human and Drosophila ERH is intriguing.
Like ERH, human and Drosophila RPS3 are structurally and
functionally very similar. They share an 83% amino acid
identity and an 89% amino acid similarity [23] and both have
been shown to be DNA repair proteins [16, 18]. It may be that
the roles and mechanisms of ERH and RPS3 in growth and
DNA repair are conserved between humans and Drosophila.
RPL19 and RPS3 are both upregulated in high growth
situations, specifically in certain cancer cells [24–27]. RPS3
has also been shown to be a transcription factor. As a subunit
of NF-𝜅B, it is responsible for the activation of specific
NF-𝜅B target genes [17]. These nuclear functions, along
with previously identified nuclear functions, implicate ERH
in transcription initiation, transcription elongation, mRNA
splicing, DNA synthesis, andDNA repair. ERH is a very small
protein and to date the only biochemical function that has
been attributed to it is protein binding. It may be that ERH
is modulating the activity of a number of different nuclear
complexes purely through binding to specific subunits of the
complexes.
5. Conclusions
Yeast two-hybrid interaction trap assays identified RPS3,
RPL19, and DDIT4 as binding partners of ERH. Similarities
in the function of these proteins suggest a role of ERH in
DNA repair and cell growth. Amino acids 1–24 of ERH were
shown to be sufficient and necessary for the binding to RPS3
and RPL19. This region was also shown to be sufficient for
the nuclear localization of ERH. The role of this region in
these two properties of ERH suggests a model for its nuclear
localization. ERH, which appears not to have an NLS, may
be localizing to the nucleus via binding to one of its partners
which has an NLS.
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